accélération Monet Australie jean paul kress morphosys Conquête Indépendance Tâtonner
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Working Life Interview: Jean-Paul Kress, CEO of MorphoSys - Pharmafile
Jean-Paul Kress, M.D. | Morphosys de
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Morphosys-CEO Jean-Paul Kress im Interview: Das tut sich bei Morphosys - DER AKTIONÄR
Dr. Jean-Paul Kress is new CEO of MorphoSys AG - Innovations- und Gründerzentrum Biotechnologie IZB
MorphoSys on X: "Our CEO, Jean-Paul Kress, M.D., is presenting at #JPM24 on Wednesday, January 10, at 3:00 p.m. PST in San Francisco. Join via webcast for an overview of our key #
MorphoSys on X: "Congratulations to our CEO Jean-Paul Kress for being honored by @medicine_maker in their 2021 Power List https://t.co/xj45JMpr95 https://t.co/wejmu75qPH" / X
Leadership | MorphoSys
Member Spotlight: Q&A with MorphoSys - MassBio
Kress becomes new CEO of MorphoSys - BioM
BioCentury - The transition from platform to product: Jean-Paul Kress on reshaping MorphoSys
Jean-Paul Kress: MorphoSys announced that it has entered into a business combination agreement to be acquired by Novartis - OncoDaily
The CEO of Morphosys still has to deliver | Börsen-Zeitung
Jean-Paul Kress, Morphosys AG: Profile and Biography - Bloomberg Markets
Jean-Paul Kress email address & phone number | Morphosys Chairman of the Board of Management, Chief Executive Officer contact information - RocketReach
MorphoSys AG Form 6-K Current Report Filed 2023-05-04
MorphoSys AG Form 6-K Current Report Filed 2023-05-04
New CEO at Morphosys - European Biotechnology
Jean-Paul Kress, M.D. on LinkedIn: MorphoSys Enters into Business Combination Agreement to be Acquired by… | 32 comments